Target intelligence / Profile preview

ARF like GTPase 2 binding protein pseudogene 10 (ARL2BPP10)

Target
ARL2BPP10
Molecular classification
Other (Pseudogene)
01

Overview

ARF like GTPase 2 binding protein pseudogene 10 (ARL2BPP10) is designated as a pseudogene in the human genome and does not code for a functional protein[3]. Pseudogenes are typically non-functional genomic sequences related to functional genes, often arising from duplication or retrotransposition events. Unlike the closely related ARL2BP gene, which encodes a binding partner for ARL2 and is associated with certain genetic diseases, ARL2BPP10 itself is not a protein-coding therapeutic target and is unlikely to have direct molecular function as a receptor, enzyme, transporter, or other drug target[3][5]. However, some pseudogenes are transcribed and can exert regulatory roles via noncoding RNA mechanisms, such as acting as microRNA decoys or generating small interfering RNAs, which may indirectly impact gene expression or disease phenotypes[4]. There is currently no evidence that ARL2BPP10 has been involved in any diseases, interacts with drugs, or is used as a biomarker. Its primary relevance is as an annotated pseudogene rather than a clinical or pharmacological target[3][4]. This entry is primarily a pseudogene, not a receptor, enzyme, or therapeutic target. If your aim is to find a druggable protein, refer to the related protein-coding gene ARL2BP (ARF like GTPase 2 binding protein)[5].

Other names
ADP ribosylation factor like GTPase 2 binding protein pseudogene 10ADP-ribosylation factor-like 2 binding protein pseudogene 10ARL2BPP10
02

Biological functions

Possible regulatory noncoding RNA functions (general for pseudogenes[4])
03

Disease associations

Other (possible noncoding RNA regulatory roles; direct roles unknown for this pseudogene[4])

Beyond the preview

Go deeper on ARF like GTPase 2 binding protein pseudogene 10 (ARL2BPP10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARF like GTPase 2 binding protein pseudogene 10 (ARL2BPP10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call